IMR Press / FBL / Volume 12 / Issue 10 / DOI: 10.2741/2345

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article

Engineering cardiac healing using embryonic stem cell-derived cardiac cell seeded constructs

Show Less
1 Department of Chemical Engineering and Applied Chemistry, University of Toronto, 200 College Street, Toronto, Ontario, M5S 3E5, Canada
2 Institute for Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Ontario M5S 3G9, Canada
Academic Editor:Song Li
Front. Biosci. (Landmark Ed) 2007, 12(10), 3694–3712; https://doi.org/10.2741/2345
Published: 1 May 2007
(This article belongs to the Special Issue Stem cell engineering)
Abstract

Myocardial infarction is one of the leading causes of death in industrialized nations. Recent advances in tissue engineering and cell biology have changed our understanding of regenerative activities in the infarcted heart and have raised considerable hopes for novel therapeutic approaches to treat patients. Studies have shown that cell transplantation results in small improvements in the infarct area and while these therapies hold promise, significant challenges remain in order to increase both cellular engraftment efficiencies and transplanted cell function. Robust cardiac healing will require appropriate revascularization of the infarct site, mechanical recovery of damaged tissue and electrophysiological coupling with native tissue. Embryonic stem cells, uniquely, have the potential to generate bonafide cardiomyocytes and other derivatives which should contribute toward these multifaceted requirements. Guiding embryonic stem derived cells to support healing and regeneration of heart tissue using tissue engineered constructs may provide advantages over direct cell transplantation, including replacement of damaged infrastructure, temporary support for transplanted cells, and control of size, shape, strength and composition of the graft.

Keywords
Embryonic Stem Cells
Cardiac Tissue Engineering
Myocardial Infarction
Scaffold
Polyurethane
Review
Share
Back to top